A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.

One of the key challenges in the development of RNA interference-based cancer therapy is the lack of an efficient delivery system for synthetic small interfering RNAs (siRNAs) that would enable efficient uptake by tumor cells and allow for significant knockdown of a target transcript in vivo. Here, we describe a micelleplex system based on an amphiphilic and cationic triblock copolymer, which can systemically deliver siRNA targeting the acid ceramidase (AC) gene for cancer therapy. This triblock copolymer, consisting of monomethoxy poly(ethylene glycol), poly(ε-caprolactone) and poly(2-aminoethyl ethylene phosphate), self-assembles into micellar nanoparticles (MNPs) in aqueous solution with an average diameter of 60 nm and a zeta potential of approximately 48 mV. The resulting micelleplex, formed by the interaction of MNPs and siRNA, was effectively internalized by BT474 breast cancer cells and siRNA was subsequently released, resulting in significant gene knockdown. This effect was demonstrated by significant down-regulation of luciferase expression in BT474-luciferase cells which stably express luciferase, and suppression of AC expression in BT474 cells at both the transcriptional and protein level, following delivery of specific siRNAs by the micelleplex. Furthermore, a micelleplex carrying siRNA targeting the AC (micelleplex(siAC)) gene was found to induce remarkable apoptosis and reduce the proliferation of cancer cells. Systemic delivery of micelleplex(siAC) significantly inhibited tumor growth in a BT474 xenograft murine model, with depressed expression of AC and no positive activation of the innate immune response, suggesting therapeutic promise for micelleplex siRNA delivery in cancer therapy.

[1]  Y. Hannun,et al.  Molecular targeting of acid ceramidase: implications to cancer therapy. , 2008, Current drug targets.

[2]  J. Rossi,et al.  RNA‐Mediated Inhibition of HIV in a Gene Therapy Setting , 2003, Annals of the New York Academy of Sciences.

[3]  H. Uludaǧ,et al.  Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. , 2009, Biomaterials.

[4]  G. Kwon,et al.  Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins. , 2010, Molecular pharmaceutics.

[5]  K. Knutson,et al.  Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Dale L. Greiner,et al.  T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2008, Cell.

[7]  Svetlana Shulga Morskaya,et al.  5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma , 2008, Nature Medicine.

[8]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[9]  T. Park,et al.  Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. , 2010, Biomaterials.

[10]  Y. Iwasaki,et al.  Enzyme-degradable phosphorylcholine porous hydrogels cross-linked with polyphosphoesters for cell matrices. , 2007, Biomaterials.

[11]  L. Ellerby,et al.  Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[13]  Leaf Huang,et al.  Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. , 2006, Molecular pharmaceutics.

[14]  Y. Bae,et al.  Self-assembled polyethylenimine-graft-poly(ε-caprolactone) micelles as potential dual carriers of genes and anticancer drugs , 2007 .

[15]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[16]  A. Judge,et al.  Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA , 2005, Nature Biotechnology.

[17]  A. Bielawska,et al.  The functional effects of acid ceramidase over-expression in prostate cancer progression and resistance to chemotherapy , 2007, Cancer biology & therapy.

[18]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[19]  X. Shuai,et al.  Novel Biodegradable Ternary Copolymers hy-PEI-g-PCL-b-PEG: Synthesis, Characterization, and Potential as Efficient Nonviral Gene Delivery Vectors , 2003 .

[20]  John J. Rossi,et al.  The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.

[21]  A. Huwiler,et al.  Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. , 2007, Critical reviews in oncology/hematology.

[22]  A. Villanueva,et al.  Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo , 2007, Oncogene.

[23]  Shubiao Zhang,et al.  Cationic lipids and polymers mediated vectors for delivery of siRNA. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Y. Bae,et al.  Self-assembled polyethylenimine-graft-poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs. , 2007, Biomaterials.

[25]  H. Uludaǧ,et al.  Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. , 2009, Molecular pharmaceutics.

[26]  Judy Lieberman,et al.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.

[27]  X. M. Sun,et al.  Discrimination of apoptotic thymocytes by forward light scatter. , 1995, Cytometry.

[28]  Yi-Yan Yang,et al.  Synthesis and characterization of cationic micelles self-assembled from a biodegradable copolymer for gene delivery. , 2007, Biomacromolecules.

[29]  R. Kontermann,et al.  Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[31]  Judy Lieberman,et al.  Interfering with disease: a progress report on siRNA-based therapeutics , 2007, Nature Reviews Drug Discovery.

[32]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[33]  Jun Wang,et al.  Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[34]  D. Kessel,et al.  Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.

[35]  N. Kosaka,et al.  Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. , 2004, Nucleic acids research.

[36]  M. Tankersley,et al.  T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2009, Pediatrics.

[37]  Yi-Yan Yang,et al.  The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection. , 2007, Biomaterials.

[38]  X. M. Sun,et al.  Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. , 1992, The Biochemical journal.

[39]  Anton P. McCaffrey,et al.  Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.

[40]  H. Mao,et al.  Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. , 2008, Biomaterials.

[41]  K. Baek,et al.  Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[43]  C. Henderson,et al.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS , 2005, Nature Medicine.

[44]  T. Tuschl,et al.  The Human DiGeorge Syndrome Critical Region Gene 8 and Its D. melanogaster Homolog Are Required for miRNA Biogenesis , 2004, Current Biology.

[45]  B. Williams,et al.  Activation of the mammalian immune system by siRNAs , 2005, Nature Biotechnology.

[46]  R. Kolesnick The therapeutic potential of modulating the ceramide/sphingomyelin pathway. , 2002, The Journal of clinical investigation.

[47]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[48]  H. Rüdiger,et al.  Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. , 2001, Cancer research.

[49]  M. Stevenson,et al.  Modulation of HIV-1 replication by RNA interference , 2002, Nature.

[50]  Jun Wang,et al.  Biodegradable and photocrosslinkable polyphosphoester hydrogel. , 2006, Biomaterials.

[51]  Yuanming Hu,et al.  Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Mario Stevenson,et al.  Therapeutic potential of RNA interference. , 2004, The New England journal of medicine.

[53]  Leaf Huang,et al.  Nonviral methods for siRNA delivery. , 2009, Molecular pharmaceutics.

[54]  R. Juliano,et al.  Biological barriers to therapy with antisense and siRNA oligonucleotides. , 2009, Molecular pharmaceutics.

[55]  Mark E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.

[56]  G. Hannon,et al.  Unlocking the potential of the human genome with RNA interference , 2004, Nature.

[57]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[58]  Tatiana Segura,et al.  Synthesis and in vitro characterization of an ABC triblock copolymer for siRNA delivery. , 2007, Bioconjugate chemistry.

[59]  Judy Lieberman,et al.  Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. , 2006, Annual review of biomedical engineering.

[60]  John J. Rossi,et al.  Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.